One Man’s Experience Using HDK plus HC

Yesterday I wrote about using Keto (HDK) along with HC as a secondary hormone suppressant after traditional hormone blockades have failed to work. The reviews of HDK has been mixed with some doctors shying away from it because of its potential liver toxicity issues. However, for many men fighting advanced prostate cancer HDK is an [...]

Ketoconazole- A Secondary Hormone Manipulation

Ketoconazole (kee-ta-KOE-na-zol), generic name for Nizoral, is an oral drug approved by the FDA for the use to treat fungal infections. However, it has been shown that higher doses of ketoconazole (800-1200mg/day vs 200-400mg/day) also block the production of both free and bound testosterone. Since high-dose Ketoconazole (HDK) has testosterone lowering effects, operating both on [...]

Do Bisophosphonates Cause Bone Fractures?

Oh no, another not so very clear issue for men with prostate cancer has emerged! According to an article written by Tara Parker-Pope in the New York Times, bisphosphonates (i.e. Fosamax), has been reported, in some rare occasions, to actually cause weaker bones that lead to an unusual type of fracture of the femur. Bisphosphonates [...]

The Promise Of Cancer Vaccines Along With Hormone Therapy

According to Philip M. Arlen, M.D., director of the Clinical Research Group for the Laboratory of Tumor Immunology and Biology, Center for Cancer Research, at the National Cancer Institute, "Vaccines, if and when they are approved, can be safely and effectively combined with other therapies, including hormones. There appears to be an advantage in overall [...]

Maybe A Misnomer – Prostate Cancer Resistance to Androgen Deprivation Therapy

The use of ADT is the treatment of choice for advanced, metastatic prostate cancer as long as the cancer is responsive to the blockade. The theory goes that the suppression of circulating testosterone, which fuels prostate-cancer growth, whether by surgical castration (orchiectomy) or castration with testosterone-blocking drugs slows down the progression of the prostate cancer. [...]

Go to Top